Back

Introduction

31 August 2019 (15:30 - 15:35)
Organised by:
Congress Presentation Part of: PCSK9i, changing practice in cardiology: the emerging story Risk Factors and Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor John Chapman

Pitie Salpetriere APHP University Hospital, Paris (France)

4 More presentations in this session

Presentation thumbnail
Insights and lessons from the ODYSSEY outcomes trial: which patients benefit most?
Professor P. Steg (Paris, FR)
Presentation thumbnail
Extending the evidence: what did the FOURIER trial learns us on managing high risk patients?
Professor M. Sabatine (Boston, US)
Slides Video
Presentation thumbnail
Targeting PCSK9: expanding knowledge and targeting new frontiers
Professor J. Kastelein (Amsterdam, NL)
Video
Presentation thumbnail
Discussion
Professor J. Chapman (Paris, FR) Professor J. Kastelein (Amsterdam, NL)
Slides Video

Access the full session

Session thumbnail
PCSK9i, changing practice in cardiology: the emerging story

The Event

Event poster

ESC Congress 2019

31 August 2019 15:30 CET
You may be interested in
thumbnail
Congress Session
RNA-based therapy in cardiovascular disease: ready for prime time!
27 August 2023
thumbnail
Congress Presentation
Breaking through: CETP inhibitors and the future of lipid therapy
29 August 2025
thumbnail
Congress Presentation
Navigating lower limb PAD diagnosis and treatment
2 September 2024
thumbnail
Congress Presentation
Imaging-guided lipid-lowering therapy in rheumatology patients at cardiovascular risk
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources